Infected Neuropathic Foot: Investigation

  • Shelly D. Sedberry
  • Michael I. Gazes
  • Peter A. Blume


Early diagnosis and management of diabetes and neuropathy can aid in the prevention of ulcerations and amputations. Care is best delivered through a multidisciplinary approach. High risk patients should be identified during routine foot exams. Clinical diagnosis and valuable imaging modalities can assist with diagnosing infection, which should be treated appropriately and timely to achieve the most successful outcomes. Effective preventative interventions to avoid infection should include strict glycemic control, smoking cessation and vascular health, intensive podiatric care, offloading of high pressure locations, and debridement of wounds and calluses.


Off loading Wound debridement Glucose control 


  1. 1.
    Sumpio BE. Foot Ulcers. N Engl J Med. 2000;343:787–93.CrossRefGoogle Scholar
  2. 2.
    O’Brien IA, Corrall RJ. Epidemiology of diabetes and its complications. N Engl J Med. 1988;318(24):1619–20.CrossRefGoogle Scholar
  3. 3.
    Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incident of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377–84.CrossRefGoogle Scholar
  4. 4.
    Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJM. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulcerations. Diabetes Care. 1998;21:1071–5.CrossRefGoogle Scholar
  5. 5.
    Frykberg RG. Diabetic foot ulcers: pathogenesis and management. Am Fam Physician. 2002;66:1655–62.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Frykberg RG, Armstrong DG, Giurini J, et al. Diabetic foot disorders; a clinical practice guideline. J Foot Ankle Surg. 2000;39.(Suppl(1):2–60.CrossRefGoogle Scholar
  7. 7.
    Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31(8):1679–85.CrossRefGoogle Scholar
  8. 8.
    Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg. 1998;176.(Suppl 2A:5S–10S.CrossRefGoogle Scholar
  9. 9.
    Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22:157–62.CrossRefGoogle Scholar
  10. 10.
    Pecoraro RE, Reiber G, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513–21.CrossRefGoogle Scholar
  11. 11.
    Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int. 1997;18:716–22.CrossRefGoogle Scholar
  12. 12.
    Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg. 2003;17(5):571–80.CrossRefGoogle Scholar
  13. 13.
    Knox RC, Dutch W, Blume P, Sumpio BE. Diabetic Foot Disease. Int J Angiol. 2000;9:1): 1–6.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Laing P. The development and complications of diabetic foot ulcers. Am J Surg. 1998;176(2A Suppl):11S–9S.CrossRefGoogle Scholar
  15. 15.
    Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036–42.CrossRefGoogle Scholar
  16. 16.
    Clayton W Jr, Elasy TA. A review of the pathophysiology, classification and treatment of foot ulcers in diabetic patients. Clinical Diabetes. 2009;27(2):52–8.CrossRefGoogle Scholar
  17. 17.
    Wolf G. New insights into the pathophysiology of diabetic neuropathy: from hemodynamics to molecular pathology. Eur J Clin Invest. 2004;34(12):785–96.CrossRefGoogle Scholar
  18. 18.
    Veves A, Fernando D, Walewski P, Boulton AJM. A study of plantar pressures in a diabetic clinic population. Foot. 1991;2:89.CrossRefGoogle Scholar
  19. 19.
    Bauman JH, Girling JP, Brand PW. Plantar pressures and trophic ulceration. An evaluation of footwear. J Bone Joint Surg Br. 1963;45(4):652–73.CrossRefGoogle Scholar
  20. 20.
    Fernando ME, Crowther RG, Pappas E, Lazzarini PA, Cunningham M, Sangla KS et al. Plantar pressure in diabetic peripheral neuropathy patients with active foot ulceration, previous ulceration and no history of ulceration: a meta-analysis of observational studies. PLoS One. 2014;9(6):e99050. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Sumpio BE. Contemporary evaluation and management of the diabetic foot. Forensic Sci. 2012;2012:435487.Google Scholar
  22. 22.
    Casselli A, Pham H, Giurini JM, Armstrong DG, Veves A. The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care. 2002;25(6):1066–71.CrossRefGoogle Scholar
  23. 23.
    Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: a randomized controlled trial. Ann Intern Med. 1993;119:36–41.CrossRefGoogle Scholar
  24. 24.
    The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med. 1995;122(8):561.CrossRefGoogle Scholar
  25. 25.
    McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration; how great are the risks? Diabetes Care. 1995;18:216–9.CrossRefGoogle Scholar
  26. 26.
    Feng Y, Schlosser FJ, Sumpio BE. The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg. 2009;50(3):675–82.Google Scholar
  27. 27.
    Young MJ, Veves A, Breddy JL, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception threshold: a prospective study. Diabetes Care. 1998;21:1071–8.Google Scholar
  28. 28.
    Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med. 2003;20(2):159–61.CrossRefGoogle Scholar
  29. 29.
    Lipsky BA, Berendt AR. Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev. 2000;16(Suppl 1):S42–6.CrossRefGoogle Scholar
  30. 30.
    Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med. 1994;331:854–60.CrossRefGoogle Scholar
  31. 31.
    Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26:510–3.CrossRefGoogle Scholar
  32. 32.
    Lipsky BA. A report from the international consensus on diagnosing and treating infected diabetic foot. Diabetes Metab Res Rev. 2004;20(Suppl 1):S68–77.CrossRefGoogle Scholar
  33. 33.
    Day MR, Armstrong DG. Factors associated with methicillin resistance in diabetic foot infections. J Foot Ankle Surg. 1997;36(4):322–5. discussion 31CrossRefGoogle Scholar
  34. 34.
    Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJ. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med. 1999;16(9):767–71.CrossRefGoogle Scholar
  35. 35.
    Armstrong DG, Perales TA, Murff RT, Edelson GW, Welchon JG. Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc. 1996;86:224–7.CrossRefGoogle Scholar
  36. 36.
    Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–7.CrossRefGoogle Scholar
  37. 37.
    Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of inderlying osteomyelitis in diabetic patients. JAMA. 1995;273(9):721–3.Google Scholar
  38. 38.
    Lozano RM, Gonzalez Fernandez ML, Hernandez DM, Beneit Montesinos JV, Jimenez SG, Gonzalez Jurado MA. Validating the probe to bone test and other tests for diagnosing chronic osteomyelitis in the diabetic foot. Diabetes Care. 2010;33(10):2140–5.CrossRefGoogle Scholar
  39. 39.
    Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc. 2001;91:445–50.CrossRefGoogle Scholar
  40. 40.
    Meyr AJ, Singh S, Zhang X, Khilko N, Mukherjee A, Sheridan MJ, et al. Statistical reliability of bone biopsy for the diagnosis of diabetic foot osteomyelitis. J Foot Ankle Surg. 2011;50:663–7.CrossRefGoogle Scholar
  41. 41.
    Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis. 2006;42:57–62.Google Scholar
  42. 42.
    Perry CR, Pearson RL, Miller GA. Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the preoperative assessment of osteomyelitis. J Bone Joint Surg Am. 1991;73(5):745–9.CrossRefGoogle Scholar
  43. 43.
    Mackowiak PA, Jones SR, Smith JW. Diagnostic value of sinus-tract cultures in chronic osteomyelitis. JAMA. 1978;239(26):2772–5.CrossRefGoogle Scholar
  44. 44.
    Darouiche RO, Landon GC, Klima M, Musher DM, Markowski J. Arch Intern Med. 1994;154(7):753–8.CrossRefGoogle Scholar
  45. 45.
    Dinh MT, Abad CL, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis. Clin Infect Dis. 2008;47(4):519–27.CrossRefGoogle Scholar
  46. 46.
    Harmer JL, Pickard J, Stinchcombe SJ. The role of diagnostic imaging in the evaluation of suspected osteomyelitis in the foot: a critical review. Foot (Edinb). 2011;21(3):149–53.Google Scholar
  47. 47.
    Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW et al. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg. 2006;117(7 Suppl):212S–38S.Google Scholar
  48. 48.
    Gold RH, Hawkins RA, Katz RD. Bacterial Osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy. AJR. 1991;157(2):365–70.CrossRefGoogle Scholar
  49. 49.
    Kaim AH, Gross T, Schulthess GK. Imaging of chronic posttraumatic osteomyelitis. Eur Radiol. 2002;12:1193–202.CrossRefGoogle Scholar
  50. 50.
    Kapoor A, Page S, Lavaley M, Gale DR, Felson DT. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med. 2007;167:125–32.Google Scholar
  51. 51.
    Erdman WA, Tamburro F, Jayson HT, Weatherall PT, Ferry KB, Peshock RM. Osteomyelitis: characteristics and pitfalls of diagnosis with MR imaging. Radiology. 1991;180(2):533–9.CrossRefGoogle Scholar
  52. 52.
    Enderle M, Coerper S, Schweizer H, Koop A, Thelen M, Meisner C, et al. Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high resolution ultrasound. Diabetes Care. 1999;22:294–9.Google Scholar
  53. 53.
    Pineda C, Vargas A, Rodriguez AV. Imaging of osteomyelitis: current concepts. Infect Dis Clin North Am. 2006;20:789–825.CrossRefGoogle Scholar
  54. 54.
    Schauwecker DS, Park H-M, Mock BH, Burt RW, Kernick CB, Ruoff III AC et al. Evaluation of complicating osteomyelitis with Tc-99m MDP, In-111 granulocytes, and Ga-67 citrate. J Nucl Med. 1984;25:848–53.Google Scholar
  55. 55.
    Oloff L, Schulhofer S. Osteomyelitis. In: Banks A, Downy M, Martin D, Miller S, editors. McGlamry’s comprehensive textbook of foot and ankle surgery. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 2017–51.Google Scholar
  56. 56.
    Al-Sheikh W, Sfakianakis GN, Mnaymneh W, Hourani M, Heal A, Duncan RC et al. Subacute and chronic bone infections: diagnosis using In-111, Ga-67 and Tc-99m MDP bone scintigraphy and radiography. Radiology. 1985;155:501–6.Google Scholar
  57. 57.
    Tumeh SS, Aliabadi P, Weissman BN, NcNeil BJ. Chronic osteomyelitis: bone and gallium scan patterns associated with active disease. Radiology. 1986;158:685–8.Google Scholar
  58. 58.
    Harvey J, Cohen M. Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot. J Foot Ankle Surg. 1997;36(3):209–14.CrossRefGoogle Scholar
  59. 59.
    Kagna O, Srour S, Melamed E, Militianu D, Keidar Z. FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot. Eur J Nucl Med Mol Imaging. 2012;39:1545–50.CrossRefGoogle Scholar
  60. 60.
    Brown TL, Spencer HJ, Beenken KE, Alpe TL, Bartel TB, Bellamy W, et al. Evaluation of dynamic [18F]-FDG-PET imaging for the detection of acute post-surgical bone infection. PLoS One. 2012;7:e41863.CrossRefGoogle Scholar
  61. 61.
    Chisholm KA, Gilchrist JM. The Charcot joint: a modern neurologic perspective. J Clin Neuromuscul Dis. 2011;13:1–13.CrossRefGoogle Scholar
  62. 62.
    Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085.CrossRefGoogle Scholar
  63. 63.
    Loredo R, Rahal A, Garcia G, Metter D. Imaging of the diabetic foot diagnostic dilemmas. Foot Ankle Spec. 2010;3:249–64.CrossRefGoogle Scholar
  64. 64.
    Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med. 2005;22:1707–12.CrossRefGoogle Scholar
  65. 65.
    Jeffcoate W, Lima J, Nobrega L. The Charcot foot. Diabet Med. 2000;17:253–8.CrossRefGoogle Scholar
  66. 66.
    Eichenholtz SN. Charcot joints. Springfield, IL: Charles C Thomas; 1966.Google Scholar
  67. 67.
    Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg. 2002;91:195–201.CrossRefGoogle Scholar
  68. 68.
    Yu GV, Hudson JR. Evaluation and treatment of stage 0 Charcot’s neuroarthropathy of the foot and ankle. J Am Podiatr Med Assoc. 2002;92:210–20.CrossRefGoogle Scholar
  69. 69.
    Yu JS. Diabetic foot and neuroarthropathy: magnetic resonance imaging evaluation. Top Magn Reson Imaging. 1998;9:295–310.CrossRefGoogle Scholar
  70. 70.
    Morrison WB, Ledermann HP. Work-up of the diabetic foot. Radiol Clin North Am. 2002;40:1171–92.CrossRefGoogle Scholar
  71. 71.
    Sartoris DJ. Cross-sectional imaging of the diabetic foot. J Foot Ankle Surg. 1994;33:531–45.PubMedPubMedCentralGoogle Scholar
  72. 72.
    Ledermann HP, Morrison WB. Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: MR imaging. Semin Msculoskelet Radiol. 2005;9:272–83.CrossRefGoogle Scholar
  73. 73.
    Moore TE, Yuh WT, Kathol MH, el-Khoury GY, Corson JD. Abnormalities of the foot in patients with diabetes mellitus: findings on MR imaging. Am J Roentgenol. 1991;157:813–6.CrossRefGoogle Scholar
  74. 74.
    Palestro CJ, Mehta HH, Patel M, Freeman SJ, Harrington WN, Tomas MB, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med. 1998;39:346–50.PubMedPubMedCentralGoogle Scholar
  75. 75.
    Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;273:721–3.Google Scholar
  76. 76.
    Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG et al. 2012 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132–73.Google Scholar
  77. 77.
    Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentation of diabetic foot ulcers. Diabet Med. 1997;14:867–70.CrossRefGoogle Scholar
  78. 78.
    Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJM, Harless LB. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care. 2001;24:1019–22.CrossRefGoogle Scholar
  79. 79.
    Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJM. Activity patterns of patients with diabetic foot ulceration: Patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care. 2003;26:2595–7.CrossRefGoogle Scholar
  80. 80.
    Piaggesi A, Viacava P, Rizzo L,Naccarato G, Baccetti F, Romanelli M et al. Semi-quantitative analysis of the histopathological features of the neuropathic foot ulcer: effects of pressure relief. Diabetic Care. 2003;26:3123–8.Google Scholar
  81. 81.
    Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. J Am Coll Surg. 1996;183:61–4.PubMedPubMedCentralGoogle Scholar
  82. 82.
    Tallis A, Motley TA, Wunderlich RP Dickerson JE Jr, Waycaster C, Slade HB. Clinical and economic assessment of diabetic foot ulcer debridement with collagenase: results of a randomized controlled study. Clin Ther. 2013;35(11):1805–20.Google Scholar
  83. 83.
    Armstrong DG, Nguyen HC. Improvement in healing with aggressive edema reduction after debridement of foot infection in persons with diabetes. Arch Surg. 2000;135:1405–9.CrossRefGoogle Scholar
  84. 84.
    Wagner FW Jr. The diabetic foot. Orthopedics. 1987;10(1):163–74.CrossRefGoogle Scholar
  85. 85.
    Bus SA. Offloading the diabetic foot; evidence and clinical decision making. EWMA J. 2012;12(3):13–5.Google Scholar
  86. 86.
    Blume PA, Key JJ, Thakor P, Thakor S, Sumpio B. Retrospective evaluation of clinical outcomes in subjects with split-thickness skin graft: comparing V.A.C. therapy and conventional therapy in foot and ankle reconstructive surgeries. Int Wound J. 2010;7(6):480–7.CrossRefGoogle Scholar
  87. 87.
    Sumpio B, Thakor P, Mahler D, Blume P. Negative pressure wound therapy as postoperative dressing in below knee amputation stump closure of patients with chronic venous insufficiency. Wounds. 2011;23(10):301–8.PubMedPubMedCentralGoogle Scholar
  88. 88.
    Prakash SS, Krishnakumar PC. The influence of peripheral neuropathy and peripheral vascular disease in the outcome of diabetic foot management—a prospective study. Int J Med Res Health Sci. 2014;4(2):258–64.CrossRefGoogle Scholar
  89. 89.
    LoGerfo FW. Peripheral arterial occlusive disease and the diabetic: current clinical management. Heart Dis Stroke. 1992;1(6):395–7.PubMedPubMedCentralGoogle Scholar
  90. 90.
    Paraskevas KJ. BakerDM, Pompella A, Mikhailidis DP. Does diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview. Ann Vasc Surg. 2008;22(3):481–91.CrossRefGoogle Scholar
  91. 91.
    Park SC, Choi CY, Ha YI, Yang HE. Utility of toe-brachial index for diagnosis of peripheral arterial disease. Arch Plast Surg. 2012;39(3):227–31.CrossRefGoogle Scholar
  92. 92.
    Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14:29–34.CrossRefGoogle Scholar
  93. 93.
    Arya AK, Garg S, Kumar S, Meena LP,Tripathi K. Estimation of lymphocyte apoptosis in patients with chronic non-healing diabetic foot ulcers. Int J Med Sci Pub Health. 2013;2(4):766–8.Google Scholar
  94. 94.
    American Diabetes Association. Executive summary: standards of medical care in diabetes—2011.Google Scholar
  95. 95.
    Sorensen LT, Karlsmark T, Gottrup F. Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg. 2003;238:1–5.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Shelly D. Sedberry
    • 1
  • Michael I. Gazes
    • 1
  • Peter A. Blume
    • 2
  1. 1.Department of Podiatric SurgeryYale New Haven HospitalNew HavenUSA
  2. 2.Departments of Surgery, Anesthesia, and Orthopedics and RehabilitationYale School of MedicineNew HavenUSA

Personalised recommendations